Protagonist Therapeutics (PTGX) is up 34.1%, or $22.87 to $89.91.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- Midday Fly By: Trump threatens China tariffs, Kalshi valued at $5B
- Protagonist Therapeutics resumes, up 28% after report of J&J takeover talks
- Protagonist Therapeutics trading resumes
- J&J in talks to buy Protagonist Therapeutics, WSJ reports
- Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks